C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/31 (2006.01) A61K 39/09 (2006.01) C07K 14/315 (2006.01) C12N 1/21 (2006.01) A61K 39/00 (2006.01)
Patent
CA 2321106
Group B streptococcus (GBS) proteins and polynucleotides encoding them are disclosed. Said proteins are antigenic and therefore useful vaccine components for the prophylaxis or therapy of streptococcus infection in animals. Also disclosed are recombinant methods of producing the protein antigens as well as diagnostic assays for detecting streptococcus bacterial infection.
Cette invention a trait à des protéines ainsi qu'à des polypeptides du streptocoque du groupe B. Ces protéines, antigéniques, entrent, par le fait, dans la fabrication de vaccins aux fins de la prophylaxie et du traitement d'infections par streptocoque chez l'animal. Elle porte également sur des techniques de recombinaison aux fins de la production d'antigènes protéiques ainsi que sur des dosages diagnostiques permettant de déceler une infection bactérienne par streptocoque.
Boyer Martine
Brodeur Bernard R.
Charlebois Isabelle
Hamel Josee
Martin Denis
Biochem Pharma Inc.
Id Biomedical Corporation
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Group b streptococcus antigens does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Group b streptococcus antigens, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Group b streptococcus antigens will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1543927